Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
128.4 GBX | +1.10% | +5.77% | +4.05% |
04-11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
04-11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
Sales 2022 | 18.69M 23.35M 31.92M | Sales 2023 | -39.79M -49.71M -67.95M | Capitalization | 992M 1.24B 1.69B |
---|---|---|---|---|---|
Net income 2022 | 8M 9.99M 13.66M | Net income 2023 | -56M -69.95M -95.63M | EV / Sales 2022 | 57.1 x |
Net cash position 2022 | 276K 345K 471K | Net cash position 2023 | 11K 13.74K 18.78K | EV / Sales 2023 | -24.9 x |
P/E ratio 2022 |
122
x | P/E ratio 2023 |
-17.7
x | Employees | 1,208 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.81% |
Latest transcript on Syncona Limited
1 day | +1.10% | ||
1 week | +5.77% | ||
Current month | +4.39% | ||
1 month | +4.56% | ||
3 months | +8.81% | ||
6 months | +1.90% | ||
Current year | +4.05% |
Managers | Title | Age | Since |
---|---|---|---|
Annabel Clark
IRC | Investor Relations Contact | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 22-01-31 | |
Virginia Holmes
BRD | Director/Board Member | 64 | 20-12-31 |
Kemal Malik
BRD | Director/Board Member | 61 | 20-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 128.4 | +1.10% | 791,286 |
24-04-25 | 127 | +0.79% | 217,073 |
24-04-24 | 126 | +1.61% | 1,152,173 |
24-04-23 | 124 | 0.00% | 837,331 |
24-04-22 | 124 | +2.14% | 377,097 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am
More quotes1st Jan change | Capi. | |
---|---|---|
+4.05% | 1.04B | |
+16.54% | 75.59B | |
+53.03% | 16.95B | |
+3.20% | 15.78B | |
+7.21% | 13.87B | |
-0.77% | 12.3B | |
+9.67% | 12.04B | |
+6.24% | 10.88B | |
+34.86% | 10.17B | |
-1.71% | 9.7B |
- Stock Market
- Equities
- BACT Stock